NXPI vs SCNI · P/E 29, rev $12.27B vs P/E 0.2, rev $1.3M
NXP Semiconductors NV (NXPI) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
NXPI currently screens at market cap $76.47B and trailing P/E 29.0. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the NXPI and SCNI stock pages for the full models.
Not investment advice.